Article Details
Retrieved on: 2022-12-14 19:08:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The trial included 45 healthy patients and evaluated the H1N1 influenza antigen from Vaxess' partner, GC Biopharma. Delivery of the vaccine took ...
Article found on: www.drugdeliverybusiness.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here